TISSIUM
Tissue Reconstruction
3 open roles Tissue Reconstruction Paris, France 51-200 $202M raised Est. 2013
Bpifrance
European Investment Fund
BNP Paribas Developpement
Sofinnova Partners
BNP Paribas
Abingworth
About TISSIUM
TISSIUM is a medical device company developing innovative biopolymer-based solutions for tissue repair and reconstruction.
TISSIUM is listed on Rocketlist with 3 active roles. The company is categorized as Tissue Reconstruction in MedTech. TISSIUM is at Series D+ stage, with a B2B business model, headquartered in Paris, France. TISSIUM was founded in 2013. TISSIUM has raised $202M. Active roles are refreshed daily from public hiring sources.